Navigation Links
AcelRx Pharmaceuticals Hires Roman Skowronski, M.D., Ph.D. as Vice President of Clinical Development
Date:1/8/2009

REDWOOD CITY, Calif., Jan. 8 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. announced today it has hired Dr. Roman Skowronski as Vice President, Clinical Development. In this new position, Dr. Skowronski will be responsible for development and execution of clinical protocols and providing medical input and review of clinical development strategy. He will report to Dr. Pamela Palmer, the company's Chief Medical Officer.

Prior to joining AcelRx Pharmaceuticals, Dr. Skowronski was Director of Clinical Development at ALZA Corporation, a Johnson & Johnson Company. He has also held clinical research and development positions at Alexza Pharmaceuticals and Stanford University School of Medicine.

"We are extremely pleased to have recruited a candidate of Roman's caliber," stated Pamela Palmer, MD, PhD. "He brings a wealth of knowledge and experience in the management of analgesic drug development programs as well as drug-device combination products."

AcelRx Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the treatment of intermittent and acute medical conditions, with an initial emphasis on pain management.


'/>"/>
SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)...  The Large Urology Group Practice Association ... discredited recommendations by the U.S. Preventive Services Task ... USPSTF,s final recommendation, released today, instructs physicians ... test. This comes despite overwhelming opposition from urologists, ... who have confirmed the importance of these life-saving ...
(Date:5/21/2012)... Genesis Biopharma, Inc. (OTC/BB: GNBP), a ... posting of the following Letter to Shareholders to ... www.genesis-biopharma.com .  In addition, on May 15, ... and Exchange Commission its Quarterly Report for the ... 10-Q.  The Form 10-Q includes unaudited interim consolidated ...
(Date:5/18/2012)... NEW YORK, May 18, 2012  Intellect Neurosciences, ... Chain, the company,s chairman and CEO, will be ... Partnering Conference. (Logo:  http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ... presentation is "Prefibrillar Tau Neoepitopes Offer Attractive Targets ... take place on May 21st at the Intercontinental ...
(Date:5/17/2012)... an effort to voice concern on biosimilars pathways for ... Foundation (IDF) offered oral testimony at last week,s ... on draft guidance of biosimilars products. IDF urged the ... pathways in order to protect the safety of patients ... born with an immune system that is either absent ...
Breaking Biology Technology:Urologists Outraged over Government Panel's Recommendation to Stop Life-Saving Prostate Cancer Testing 2Urologists Outraged over Government Panel's Recommendation to Stop Life-Saving Prostate Cancer Testing 3Genesis Biopharma Issues Letter To Shareholders 2Genesis Biopharma Issues Letter To Shareholders 3Genesis Biopharma Issues Letter To Shareholders 4Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway 2
... as I sat at lunch sending off a series of ... how our professional lives continue to evolve dramatically, and in ... of a company that is driving the adoption of Internet ... quickly technological change continues to transform and enhance our professional ...
... Worst Phone UI Ever, in which I vented my ... Since that column, most people running start ups to develop mobile ... come to tell be about their products. Remarkably, most of these ... well-resourced Cingular and its OEM partner, HTC . ...
... - Norlight Telecommunications, Inc., which will spin ... it will roll out its new Voice over Internet ... Green Bay and Madison. , ,The facilities-based communications ... by offering integrated communications bundles of local voice, long ...
Other Biology Technology:Visions: Rimas Buinevicius, CEO of Sonic Foundry 2Visions: Rimas Buinevicius, CEO of Sonic Foundry 3More women needed in interface design 2More women needed in interface design 3More women needed in interface design 4Norlight will offer VoIP in Madison, Green Bay 2
(Date:5/21/2012)... by financial strategists to determine what shares to purchase ... develop a diversified portfolio of another kind -- land ... uncertainty about climate change. , Instead of plugging into ... stock, University of Illinois environmental economist Amy Ando and ... of the Prairie Pothole Region of the northern Great ...
(Date:5/21/2012)... . ,, Castor oil is known primarily as ... times with pregnant women to induce labour. Only now have ... Research succeeded in unravelling the mysteries of the action mechanism. ... of the intestine and uterus is apparently responsible. This is ... obtained from the seeds of the castor oil plant ...
(Date:5/21/2012)... Ind. - Researchers at Purdue University are working with ... Reed National Military Medical Center to create a new ... brain aneurisms including those caused by head trauma from ... might be inserted at the site of an aneurism ... vessel," said Jean Paul Allain, an associate professor of ...
Breaking Biology News(10 mins):Financial tool considered climate change uncertainty to select land for conservation 2Financial tool considered climate change uncertainty to select land for conservation 3G protein-coupled receptor mediates the action of castor oil 2G protein-coupled receptor mediates the action of castor oil 3Purdue professor to speak before Congress about nanotechnology in brain treatment research 2Purdue professor to speak before Congress about nanotechnology in brain treatment research 3Van Andel research institute study provides new details of fundamental cellular process 23429 1Internal Fixation Systems Announces 510 28k 29 Approval Granted by FDA for Subtalar Implants 23671 1Internal Fixation Systems Announces 510 28k 29 Approval Granted by FDA for Subtalar Implants 23671 2Parents May Hold Key to Treating Kids Obesity 88758 1Parents May Hold Key to Treating Kids Obesity 88758 2
... Fund (WWF) is alarmed by the dramatic decline of at ... Wildlife Reserve in Nepal, once a refuge that boasted among ... Himalayas. The recent survey of April 2008 showed a population ... , The Government of Nepal made a low-key announcement ...
... to produce a lot of a substance -- such as ... molecules that speed chemical reactions. Many jobs require highly specialized ... connect with certain molecules can be difficult. Natural catalysts, such ... food, get around this problem by shape-shifting to suit the ...
... With the goal of developing an accurate, powerful ... bone strength, scientists of the ETH Zurich Departments ... teamed up with supercomputing experts at IBM,s Zurich ... the team combines density measurements with a large-scale ...
Other Biology News:Tigers disappear from Himalayan refuge 2Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3ETH Zurich and IBM improve diagnosis of osteoporosis 2
Monoclonal Antibody to GLP Immunogen: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)...
Biotin anti-human CD164...
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
... SeeDNA co-precipitant, 250 ... pink color ensures easy ... nucleic acid recovery.Chemically inert, ... biology applications.Simple 5-minute protocol. ...
Biology Products: